Daratumumab

CAS No.: 945721-28-8

Chemical Name:: Daratumumab

Synonyms: Daratumumab;Daratumumab USP/EP/BP;Daratumumab 21.7mg/ml;Daratumumab - 20mg/ml in water;Research Grade Daratumumab(DHD80801);Anti-Human CD38, Human Antibody,myeloma,inhibit,tumor,antibody,cell,adhesion,cytotoxicity,Inhibitor,Daratumumab

CBNumber:: CB22738138

Molecular Formula:

Molecular Weight:: 0

MOL File:: Mol file

Modify Date:: 2024/7/2 8:55:03

Request For Quotation

Daratumumab Properties

form	Liquid
color	Colorless to light yellow
CAS DataBase Reference	945721-28-8

Daratumumab Preparation Products And Raw materials

Raw materials

Preparation Products

Daratumumab Suppliers

Global( 50)Suppliers

Supplier	Tel	Country	ProdList	Advantage	Inquiry
CLEARSYNTH LABS LTD.	+91-22-45045900	Hyderabad, India	6351	58	Inquiry
Hubei Ipure Biology Co., Ltd	+8613367258412	China	10326	58	Inquiry
Shanghai Minbiotech Co., Ltd.	+8617315815539	CHINA	129	58	Inquiry
Dideu Industries Group Limited	+86-29-89586680 +86-15129568250	China	26721	58	Inquiry
Nantong HI-FUTURE Biology Co., Ltd.	+undefined18051384581	China	3136	58	Inquiry
TargetMol Chemicals Inc.	+1-781-999-5354	United States	19973	58	Inquiry
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	China	9708	58	Inquiry
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	China	5319	58	Inquiry
Hubei wei shi reagent group ltd., company	027-027-59102966 18717199209	China	5878	58	Inquiry
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.	+86-027-59232304 15387063101	China	9904	58	Inquiry

Supplier	Advantage
CLEARSYNTH LABS LTD.	58
Hubei Ipure Biology Co., Ltd	58
Shanghai Minbiotech Co., Ltd.	58
Dideu Industries Group Limited	58
Nantong HI-FUTURE Biology Co., Ltd.	58
TargetMol Chemicals Inc.	58
Shanghai EFE Biological Technology Co., Ltd.	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Hubei wei shi reagent group ltd., company	58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.	58

945721-28-8(Daratumumab)Related Search:

Infliximab Rituximab Adalimumab Ustekinumab Nivolumab

Bevacizumab OMALIZUMAB Lambrolizumab Dulaglutide palivizumab

Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer Atezolizumab Denosumab CETUXIMAB Evolocumab

Ramucirumab ipilimumab Eculizumab

chevron_left

1of4

chevron_right

Daratumumab Daratumumab - 20mg/ml in water Daratumumab 21.7mg/ml Daratumumab USP/EP/BP Research Grade Daratumumab(DHD80801) Anti-Human CD38, Human Antibody,myeloma,inhibit,tumor,antibody,cell,adhesion,cytotoxicity,Inhibitor,Daratumumab 945721-28-8